Guizhou Xinbang Pharmaceutical Co., Ltd. (SHE:002390)

Market Cap	6.11B -5.3%
Revenue (ttm)	5.44B -7.6%
Net Income	127.70M +52.4%
EPS	0.07 +51.7%
Shares Out	1.90B
PE Ratio	47.79
Forward PE	n/a
Dividend	0.09 (2.86%)
Ex-Dividend Date	May 21, 2026

Volume	17,652,400
Average Volume	27,999,913
Open	3.220
Previous Close	3.220
Day's Range	3.130 - 3.220
52-Week Range	2.960 - 4.150
Beta	0.27
RSI	40.83
Earnings Date	Apr 21, 2026

About SHE:002390

Guizhou Xinbang Pharmaceutical Co., Ltd. manufactures and sells traditional Chinese medicine and other pharmaceutical products in China and internationally. The company cardiovascular and cerebrovascular, digestive system, endocrine, tumors and immunomodulatory drugs, blood system drugs, rheumatism and rheumatoid arthritis, urinary system, antipyretic and analgesic, cold medicine, gynecological medications, and anti-infective drugs. It also provides medical services. The company was founded in 1995 and is headquartered in Guiyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 5,059
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002390

Financial Performance

In 2025, SHE:002390's revenue was 5.62 billion, a decrease of -6.84% compared to the previous year's 6.03 billion. Earnings were 120.29 million, an increase of 18.65%.